Month: February 2026
Novartis receives positive CHMP opinion for remibrutinib in chronic spontaneous urticaria (CSU)
Written by Customer Service on . Posted in Public Companies.
Jura Provides Disclosure Regarding Shareholder Claim by PEL’s CEO
Written by Customer Service on . Posted in Public Companies.
BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Amneal Reports Fourth Quarter and Full Year 2025 Financial Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Banco Itaú Chile Announces Fourth Quarter 2025 Management Commentary
Written by Customer Service on . Posted in Public Companies.
Ipsen receives positive CHMP opinion for Ojemda® for the treatment as monotherapy of children with relapsed or refractory BRAF-altered pediatric low-grade glioma
Written by Customer Service on . Posted in Public Companies.
Pro Kapital Council approved Consolidated Interim Report for IV Quarter and 12 Months of 2025 (Unaudited)
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Pro Kapital Council approved Consolidated Interim Report for IV Quarter and 12 Months of 2025 (Unaudited)
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Press Release: Acoziborole Winthrop, developed by DNDi and Sanofi, receives CHMP positive opinion as three-tablet, single-dose treatment for most common form of sleeping sickness
Written by Customer Service on . Posted in Public Companies.
